Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1173-1181
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1173
Table 1 Baseline characteristics of diabetic patients n (%)
Endoscopic resection (n = 85)Subtotal gastrectomy (n = 218)Total gastrectomy (n = 57)P
Male39 (45.9)142 (65.1)40 (70.2)0.0031
Age at treatment (yr, mean ± SE)64.9 ± 7.465.1 ± 8.764.1 ± 8.50.74
Comorbid HTN57 (67.1)120 (55.0)29 (50.9)0.09
Diabetes medication
Sulfonylurea (S)72 (84.7)178 (81.7)47 (82.5)0.82
Metformin (M)42 (49.4)126 (57.8)30 (52.6)0.39
α-glucosidase inhibitor20 (23.5)45 (20.6)19 (33.3)0.13
Thiazolidinedione (T)8 (9.4)16 (7.3)1 (1.8)0.20
Insulin54 (63.5)181 (83.0)47 (82.5)0.0011
Combination (M, S)3 (3.5)5 (2.3)2 (3.5)0.73
Combination (M, T)1 (1.2)2 (0.9)0 (0.0)1.00
Others1 (1.2)9 (4.1)1 (1.8)0.48
Diabetes medications (n)
112 (14.1)22 (10.1)6 (10.5)0.24
238 (44.7)79 (36.2)23 (40.4)
325 (29.4)85 (39.0)15 (26.3)
≥ 410 (11.8)32 (14.7)13 (22.8)